Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-cli
Applied Integrin Sciences, Inc. announced today that its first cancer therapeutic drug candidate eliminated all intraperitoneal ovarian cancer tumors in a pre-clinical study testing a novel treatment regimen.